Scientists dig into tumor samples to crack resistance in HER2 breast cancer
Knowledge-focused
Recruiting now
This study examines stored tumor samples from 10 people with HER2-positive breast cancer who still had cancer after standard chemo and trastuzumab. Researchers will compare samples taken before and after treatment to see how the tumor and its surroundings changed. The goal is to …
Sponsor: Giampaolo Bianchini • Aim: Knowledge-focused
Last updated May 26, 2026 06:12 UTC